Court Properly Dismissed Most Securities Claims Against Drug Maker, Panel Rules

(December 7, 2016, 1:30 PM EST) -- BOSTON — A First Circuit U.S. Court of Appeals panel on Nov. 28 substantially affirmed a federal district court’s dismissal of claims in a securities class action lawsuit against a pharmaceutical...
To view the full article, register now.